Author Archives: Dina

Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official — and Novo Nordisk Has a Problem – fool.com

Eli Lilly (LLY -0.52%) is already the leader in the weight-loss market thanks to Zepbound, the best-selling medication in this space. However, the drugmaker has been making headlines with its next-gen anti-obesity medicine, retatrutide. Eli Lilly recently announced that it will request approval from the U.S. Food and Drug Administration for retatrutide in the first…

Read more
1 26 27 28 29 30 88